OCA at 07:29, 22 November 2023

OCA — Wed, 22 Nov 2023 07:29:23 GMT

←Older revision		Revision as of 07:29, 22 November 2023
Line 1:		Line 1:
-	'''Unreleased structure'''

-	The ~~entry~~ 8j5j is ~~ON HOLD~~	+	==The crystal structure of bat coronavirus RsYN04 RBD bound to the antibody S43==
		+	<StructureSection load='8j5j' size='340' side='right'caption='[[8j5j]], [[Resolution\|resolution]] 3.00Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[8j5j]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Betacoronavirus_sp. Betacoronavirus sp.] and [https://en.wikipedia.org/wiki/Vicugna_pacos Vicugna pacos]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8J5J OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8J5J FirstGlance]. <br>
		+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 3Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8j5j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8j5j OCA], [https://pdbe.org/8j5j PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8j5j RCSB], [https://www.ebi.ac.uk/pdbsum/8j5j PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8j5j ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/A0A8F0ZU44_9BETC A0A8F0ZU44_9BETC] Spike protein S1: attaches the virion to the cell membrane by interacting with host receptor, initiating the infection.[HAMAP-Rule:MF_04099] Spike protein S2': Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.[HAMAP-Rule:MF_04099] Spike protein S2: mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.[HAMAP-Rule:MF_04099]
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Following the outbreak of coronavirus disease 2019 (COVID-19), several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related coronaviruses have been discovered. Previous research has identified a novel lineage of SARS-CoV-2-related CoVs in bats, including RsYN04, which recognizes human angiotensin-converting enzyme 2 (ACE2) and thus poses a potential threat to humans. Here, we screened the binding of the RsYN04 receptor-binding domain (RBD) to ACE2 orthologs from 52 animal species and found that the virus showed a narrower ACE2-binding spectrum than SARS-CoV-2. However, the presence of the T484W mutation in the RsYN04 RBD broadened its range. We also evaluated 44 SARS-CoV-2 antibodies targeting seven epitope communities in the SARS-CoV-2 RBD, together with serum obtained from COVID-19 convalescents and vaccinees, to determine their cross-reaction against RsYN04. Results showed that no antibodies, except for the RBD-6 and RBD-7 classes, bound to the RsYN04 RBD, indicating substantial immune differences from SARS-CoV-2. Furthermore, the structure of the RsYN04 RBD in complex with cross-reactive antibody S43 in RBD-7 revealed a potently broad epitope for the development of therapeutics and vaccines. Our findings suggest RsYN04 and other viruses belonging to the same clade have the potential to infect several species, including humans, highlighting the necessity for viral surveillance and development of broad anti-coronavirus countermeasures.

-	~~Authors~~:	+	Cross-species recognition of bat coronavirus RsYN04 and cross-reaction of SARS-CoV-2 antibodies against the virus.,Zhao R, Niu S, Han P, Gao Y, Liu D, Luo C, Liu H, Liu B, Xu Y, Qi J, Chen Z, Shi W, Wu L, Gao GF, Wang Q Zool Res. 2023 Nov 18;44(6):1015-1025. doi: 10.24272/j.issn.2095-8137.2023.187. PMID:37804113<ref>PMID:37804113</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
		+	<div class="pdbe-citations 8j5j" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Betacoronavirus sp]]
		+	[[Category: Large Structures]]
		+	[[Category: Vicugna pacos]]
		+	[[Category: Gao GF]]
		+	[[Category: Han P]]
		+	[[Category: Niu S]]
		+	[[Category: Qi JX]]
		+	[[Category: Wang QH]]
		+	[[Category: Zhao RC]]

OCA: Protected "8j5j" [edit=sysop:move=sysop]

OCA — Wed, 03 May 2023 05:31:32 GMT

Protected "8j5j" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:31, 3 May 2023

OCA: New page: '''Unreleased structure''' The entry 8j5j is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 03 May 2023 05:31:31 GMT

New page: '''Unreleased structure''' The entry 8j5j is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 8j5j is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

8j5j - Revision history

OCA at 07:29, 22 November 2023

OCA: Protected "8j5j" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8j5j is ON HOLD Authors: Description: Category: Unreleased Structures